- Home
- BRTX vs USEA Comparison
BRTX vs USEA Comparison
Compare BRTX & USEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- USEA
- Stock Information
- Founded
- BRTX 1997
- USEA 2004
- Country
- BRTX United States
- USEA Greece
- Employees
- BRTX N/A
- USEA N/A
- Industry
- BRTX Managed Health Care
- USEA Marine Transportation
- Sector
- BRTX Health Care
- USEA Consumer Discretionary
- Exchange
- BRTX Nasdaq
- USEA Nasdaq
- Market Cap
- BRTX 12.6M
- USEA 10.5M
- IPO Year
- BRTX N/A
- USEA N/A
- Fundamental
- Price
- BRTX $1.67
- USEA $1.43
- Analyst Decision
- BRTX Strong Buy
- USEA Strong Buy
- Analyst Count
- BRTX 1
- USEA 1
- Target Price
- BRTX $18.00
- USEA $6.00
- AVG Volume (30 Days)
- BRTX 256.1K
- USEA 202.3K
- Earning Date
- BRTX 08-12-2025
- USEA 08-05-2025
- Dividend Yield
- BRTX N/A
- USEA 2.76%
- EPS Growth
- BRTX N/A
- USEA N/A
- EPS
- BRTX N/A
- USEA N/A
- Revenue
- BRTX $391,000.00
- USEA $42,595,000.00
- Revenue This Year
- BRTX $391.52
- USEA N/A
- Revenue Next Year
- BRTX $3.50
- USEA $11.62
- P/E Ratio
- BRTX N/A
- USEA N/A
- Revenue Growth
- BRTX 161.54
- USEA N/A
- 52 Week Low
- BRTX $1.21
- USEA $1.00
- 52 Week High
- BRTX $2.55
- USEA $2.78
- Technical
- Relative Strength Index (RSI)
- BRTX 46.78
- USEA 55.20
- Support Level
- BRTX $1.57
- USEA $1.40
- Resistance Level
- BRTX $1.72
- USEA $1.57
- Average True Range (ATR)
- BRTX 0.13
- USEA 0.13
- MACD
- BRTX -0.01
- USEA 0.00
- Stochastic Oscillator
- BRTX 20.65
- USEA 29.17
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About USEA United Maritime Corporation
United Maritime Corp operates as a shipping company currently specializing in the seaborne transportation of dry bulk commodities. It currently operates one LR2 tanker vessel and three Capesize dry bulk vessels, two Kamsarmax dry bulk vessels, and three Panamax dry bulk vessels, with an aggregate cargo-carrying capacity of approximately 1,004,289 dwt.